Encainida [Spanish]
Encainida [Spanish] Brand names, Encainida [Spanish] Analogs
Encainida [Spanish] Brand Names Mixture
- No information avaliable
Encainida [Spanish] Chemical_Formula
C22H28N2O2
Encainida [Spanish] RX_link
No information avaliable
Encainida [Spanish] fda sheet
Encainida [Spanish] msds (material safety sheet)
Encainida [Spanish] Synthesis Reference
No information avaliable
Encainida [Spanish] Molecular Weight
352.47 g/mol
Encainida [Spanish] Melting Point
No information avaliable
Encainida [Spanish] H2O Solubility
No information avaliable
Encainida [Spanish] State
Solid
Encainida [Spanish] LogP
4.427
Encainida [Spanish] Dosage Forms
No information avaliable
Encainida [Spanish] Indication
For management of irregular heartbeats to a normal rhythm.
Encainida [Spanish] Pharmacology
Used to treat irregular heartbeats, encainide decreases excitability, conduction velocity, and automaticity as a result of slowed atrial, atrioventricular (AV) nodal, His-Purkinje, and intraventricular conduction. It causes a slight but significant prolongation of refractory periods in these tissues. The greatest effect is on the His-Purkinje system. Encainide decreases the rate of rise of the action potential without markedly affecting its duration.
Encainida [Spanish] Absorption
No information avaliable
Encainida [Spanish] side effects and Toxicity
No information avaliable
Encainida [Spanish] Patient Information
No information avaliable
Encainida [Spanish] Organisms Affected
Humans and other mammals
![Encainida_[Spanish]](/images/rx/APRD00613.gif)
